Skip to main content

Table 2 iBAT mass, triacylglyerol and protein content

From: Dietary n-3 long-chain polyunsaturated fatty acids upregulate energy dissipating metabolic pathways conveying anti-obesogenic effects in mice

Mass C HF HF/n-3
iBAT (mg) 179.3 ± 21.2 312 ± 15.5a 246.8 ± 18.2a, b
Subgroup (n = 5)
 TAG (mg)/g iBAT 92.6 ± 9.3 118.1 ± 13.7 118.4 ± 12.7
 TAG (mg) in total iBAT 20.7 ± 1.6 40.7 ± 6.9a 32.1 ± 5.6
 Protein (mg)/g iBAT 49.2 ± 3.6 37.0 ± 1.3a 45.4 ± 2.0
 Protein (mg) in total iBAT 11.2 ± 1.1 12.5 ± 0.7 11.9 ± 1.2
 TAG (mg)/protein (mg) 1.9 ± 0.1 3.3 ± 0.5a 2.6 ± 0.2
  1. All data are means ± SEM and were collected from mice after 12-week feeding either control (C), HFD (HF), or n-3 long-chain polyunsaturated fatty acid (LCPUFA)-enriched HFD (HF/n-3). Index letters a and b indicate a significant difference (p < 0.05) compared to C and HF group, respectively
  2. iBAT interscapular brown adipose tissue, TAG triacylglycerol